Companies: 10,795·Total market cap: $144.5T
Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA

FSNUFOTCHealthcare● Active
$57.00
+$2.65(+4.88%)
Market Cap$32.1B
P/E Ratio—
52W High$58.16
52W Low$37.73
Shares OutstandingFinancialsRevenue

Fresenius SE & Co. KGaA (FSNUF) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

FSNUF · shares outstanding · updated Jun 8, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
563.2M▲ +0.00% YoY Change
FY · as of Dec 31, 2025 · Reported in EUR
vs 563.2M in FY 2024
Diluted Shares Outstanding
563.2M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+0.00%
year-over-year
Float (Free Float)
410.5M
publicly tradable shares
72.9% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-08

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+0.1%
2022 → 2025
5-Year CAGRincreasing
+0.2%
2020 → 2025
10-Year CAGRincreasing
+0.3%
2015 → 2025
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 563.2M
563.2M
+0.00%
FY 2024
Diluted Shares: 563.2M
563.2M
+0.51%
FY 2023
Diluted Shares: 563.2M
560.4M
-0.16%
FY 2022
Diluted Shares: 561.3M
561.3M
+0.57%
FY 2021
Diluted Shares: 558.2M
558.1M
+0.11%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs FSNUF
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+344.2%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+331.2%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+216.1%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+175.2%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+61.6%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+59.4%
#7
Fresenius SE & Co. KGaAFSNUF
Fresenius SE & Co. KGaAYOU
563.2M—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Fresenius SE & Co. KGaA (FSNUF) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2025, Fresenius SE & Co. KGaA reports 563.2M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Fresenius SE & Co. KGaA's basic shares outstanding (563.2M) represents currently issued shares. Diluted shares outstanding (563.2M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Fresenius SE & Co. KGaA's float is 410.5M (72.9% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float410.5M(72.9%)
Outstanding563.2M

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · EUR

About shares outstanding & methodology

Fresenius SE & Co. KGaA (FSNUF) shares outstanding history from 2006 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Fresenius SE & Co. KGaA shares outstanding for the fiscal year ending December 31, 2025 were 563.2M, a 0.00% increase year-over-year. Fresenius SE & Co. KGaA FY 2025 shares outstanding were 563.2M, a +0.00% increase from FY 2024.

Fresenius SE & Co. KGaA is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +0.3% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

FSNUF shares outstanding · 4 questions

As of December 31, 2025, Fresenius SE & Co. KGaA (FSNUF) has approximately 563.2M basic shares outstanding and 563.2M diluted shares outstanding. This represents a +0.00% year-over-year increase from FY 2024 (563.2M). The increase may reflect equity compensation issuances or secondary offerings.

FSNUF shares outstandinghow many shares does FSNUF haveFSNUF basic shares 2025FSNUF diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Fresenius SE & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-08